Abadan Faculty of Medical Sciences, P.O. Box 6313833177, Abadan, Iran.
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
Biol Trace Elem Res. 2021 Apr;199(4):1291-1296. doi: 10.1007/s12011-020-02271-z. Epub 2020 Jul 1.
Leishmaniasis is a widespread tropical infection; cutaneous leishmaniasis (CL) is the most common form of this disease known to cause significant morbidity. Trace metals, including selenium, zinc, iron, and copper, are required for the activity of several enzymes involved in immune system responses. The aim of this research was to measure the serum levels of selenium (Se), zinc (Zn), copper (Cu), iron (Fe), and Zn/Cu ratio in patients with CL. In this case-control study, 80 patients with CL and 80 healthy volunteers (not exposed to CL) from a CL endemic region in southwest Iran agreed to participate. Both clinical and parasitological verifications were made to include each subject as a CL-positive case. A questionnaire was completed for each participant which included the following criteria: age (year), height (cm), weight (kg), body mass index (kg/m), and duration of disease (day). The biochemical assays were performed according to the standard protocols, and the values of Zn, Cu, Se, and Fe were expressed in micrograms per deciliter (μg/dl). All results were expressed as mean ± standard deviation (SD), and the statistical significance level was defined to be less than 0.05 (P < 0.05). There were no statistically significant differences in terms of mean values of age, body weight, height, and body mass index between CL patients and the control group (P > 0.05). The mean ± SD concentrations of Zn, Fe, and Se in the control group were found to be 118.87 ± 6.35 μg/dl, 123.00 ± 8.40 μg/dl, and 11.26 ± 1.88 μg/dl, respectively. These trace elements (TEs) were statistically lower (P < 0.001) in patients with CL (case group) with values of 83.05 ± 7.32 μg/dl for Zn, 86.51 ± 10.09 μg/dl for Fe, and 3.83 ± 1.20 μg/dl for Se. We have also observed that serum levels of Cu in CL-positive group were significantly higher than in the controls (P < 0.001). Furthermore, CL patients had significantly lower Zn/Cu ratio than controls (0.63 ± 0.05 μg/dl vs. 1.11 ± 0.10; P < 0.001). The alternation in serum levels of TEs may be a part of the defense strategy of the organism. Based on these results, it can be suggested that serum levels of these TEs can be a useful marker to estimate the prognosis of CL infection.
利什曼病是一种广泛存在的热带感染病;皮肤利什曼病(CL)是这种疾病最常见的形式,已知其会导致严重的发病率。硒、锌、铁和铜等痕量金属是参与免疫系统反应的几种酶活性所必需的。本研究的目的是测量 CL 患者的血清硒(Se)、锌(Zn)、铜(Cu)、铁(Fe)和 Zn/Cu 比值。在这项病例对照研究中,来自伊朗西南部 CL 流行地区的 80 名 CL 患者和 80 名健康志愿者(未接触过 CL)同意参与。对每个受试者进行临床和寄生虫学验证,以将其纳入 CL 阳性病例。每位参与者填写一份问卷,其中包括以下标准:年龄(岁)、身高(cm)、体重(kg)、体重指数(kg/m)和疾病持续时间(天)。根据标准方案进行生化检测,Zn、Cu、Se 和 Fe 的值以微克/分升(μg/dl)表示。所有结果均表示为平均值±标准偏差(SD),统计学显著性水平定义为小于 0.05(P<0.05)。CL 患者和对照组在平均年龄、体重、身高和体重指数方面无统计学差异(P>0.05)。对照组 Zn、Fe 和 Se 的平均±SD 浓度分别为 118.87±6.35μg/dl、123.00±8.40μg/dl 和 11.26±1.88μg/dl。这些痕量元素(TEs)在 CL 患者(病例组)中明显较低(P<0.001),Zn 为 83.05±7.32μg/dl、Fe 为 86.51±10.09μg/dl、Se 为 3.83±1.20μg/dl。我们还观察到 CL 阳性组的血清 Cu 水平明显高于对照组(P<0.001)。此外,CL 患者的 Zn/Cu 比值明显低于对照组(0.63±0.05μg/dl 比 1.11±0.10μg/dl;P<0.001)。TEs 血清水平的改变可能是机体防御策略的一部分。基于这些结果,可以认为这些 TEs 的血清水平可以作为估计 CL 感染预后的有用标志物。